Free Trial

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) CEO Robert G. Jr. Spignesi Sells 11,617 Shares

Rapid Micro Biosystems logo with Medical background

Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) CEO Robert G. Jr. Spignesi sold 11,617 shares of the stock in a transaction dated Thursday, July 10th. The stock was sold at an average price of $3.40, for a total transaction of $39,497.80. Following the transaction, the chief executive officer owned 944,015 shares in the company, valued at approximately $3,209,651. The trade was a 1.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Rapid Micro Biosystems Stock Performance

RPID stock traded down $0.10 during trading on Thursday, reaching $3.37. The company had a trading volume of 68,661 shares, compared to its average volume of 196,931. The firm has a 50-day simple moving average of $3.29 and a 200-day simple moving average of $2.55. The company has a market cap of $147.71 million, a price-to-earnings ratio of -3.27 and a beta of 1.32. Rapid Micro Biosystems, Inc. has a twelve month low of $0.63 and a twelve month high of $4.04.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.27) by $0.01. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative return on equity of 56.07%. The company had revenue of $7.21 million during the quarter, compared to analyst estimates of $6.63 million. Sell-side analysts expect that Rapid Micro Biosystems, Inc. will post -1.1 earnings per share for the current year.

Hedge Funds Weigh In On Rapid Micro Biosystems

Several institutional investors have recently made changes to their positions in the company. Parkman Healthcare Partners LLC purchased a new position in shares of Rapid Micro Biosystems during the 1st quarter valued at approximately $1,942,000. ABG WTT Global Life Science Capital Partners GP Ltd raised its position in Rapid Micro Biosystems by 78.0% during the first quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company's stock worth $4,880,000 after acquiring an additional 810,000 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in shares of Rapid Micro Biosystems in the first quarter valued at about $289,000. American Century Companies Inc. acquired a new stake in shares of Rapid Micro Biosystems in the first quarter valued at about $31,000. Finally, Informed Momentum Co LLC acquired a new stake in shares of Rapid Micro Biosystems in the first quarter valued at about $467,000. 52.60% of the stock is owned by hedge funds and other institutional investors.

Rapid Micro Biosystems Company Profile

(Get Free Report)

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Featured Stories

Insider Buying and Selling by Quarter for Rapid Micro Biosystems (NASDAQ:RPID)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Rapid Micro Biosystems Right Now?

Before you consider Rapid Micro Biosystems, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapid Micro Biosystems wasn't on the list.

While Rapid Micro Biosystems currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines